Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00366418
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2006-08-17
Brief Title:
Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
060228
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Heart Lung and Blood Institute NHLBI
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None